Squarepoint Ops LLC raised its position in shares of Steris PLC (NYSE:STE) by 396.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,906 shares of the medical equipment provider’s stock after purchasing an additional 48,635 shares during the period. Squarepoint Ops LLC owned 0.07% of Steris worth $8,800,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Squar Milner Financial Services LLC raised its stake in shares of Steris by 225.9% during the 3rd quarter. Squar Milner Financial Services LLC now owns 176 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 122 shares in the last quarter. Ropes Wealth Advisors LLC acquired a new position in shares of Steris during the 2nd quarter valued at about $26,000. Quest Capital Management Inc. ADV acquired a new position in shares of Steris during the 3rd quarter valued at about $26,000. Krane Funds Advisors LLC acquired a new position in shares of Steris during the 2nd quarter valued at about $27,000. Finally, CWM LLC increased its holdings in shares of Steris by 130.9% during the 3rd quarter. CWM LLC now owns 187 shares of the medical equipment provider’s stock valued at $27,000 after acquiring an additional 106 shares during the last quarter. 86.77% of the stock is owned by institutional investors.
Separately, ValuEngine lowered Steris from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $148.20.
Steris (NYSE:STE) last issued its quarterly earnings data on Monday, November 4th. The medical equipment provider reported $1.32 EPS for the quarter, beating the Zacks’ consensus estimate of $1.26 by $0.06. The business had revenue of $736.84 million for the quarter, compared to analyst estimates of $717.79 million. Steris had a return on equity of 16.15% and a net margin of 11.59%. The firm’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.10 EPS. As a group, equities research analysts forecast that Steris PLC will post 5.6 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Tuesday, November 26th will be issued a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date of this dividend is Monday, November 25th. Steris’s dividend payout ratio is 30.27%.
In other news, VP John Adam Zangerle sold 1,000 shares of the stock in a transaction dated Friday, October 4th. The stock was sold at an average price of $142.15, for a total transaction of $142,150.00. Corporate insiders own 2.36% of the company’s stock.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.